THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Closing Glance: Pharmaceuticals

Email|Print|Single Page| Text size +
March 27, 2008

NEW YORK—Shares of large pharmaceutical companies remained mostly stable Thursday, as the broader market slid on a concerns over an economic slowdown and Oracle Corp.'s worse-than-expected third-quarter sales.

The American Stock Exchange's Pharmaceutical Index rose .78 points to 299.15. Meanwhile, the Dow Jones industrial average fell 120.40 points to 12,302.70 and the technology heavy Nasdaq fell 43.53 points to 2,280.83. The Standard & Poor's 500 index fell 15.37 points to 1,325.76.

Here's how some key drug makers fared Thursday:

Madison, N.J.-based Wyeth rose a penny to $41.84.

Whitehouse Station, N.J.-based Merck & Co. shares rose 8 cents to $44.78.

Indianapolis-based Eli Lilly & Co. shares rose 24 cents to $50.43.

New York-based Pfizer Inc. fell 13 cents to $20.56.

more stories like this

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.